Amsterdam, the Netherlands, August 25, 2016 – LSP’s portfolio company Mint Solutions Holding BV, a private Dutch company developing and marketing the revolutionary medication safety system MedEye, has raised €5 million in a Series B equity funding round led by the Brabant Development Agency (BOM Capital) and current shareholders LSP (Life Sciences Partners), investing from its LSP Health Economics Fund, and Seventure Partners.
The new funds will be used to support the rollout of Mint’s proprietary MedEye system, which aims to stop and prevent medication errors and to improve efficiency in hospitals and care institutions. A link to the company's press release can be found here.
About Mint/MedEye
Mint Solutions is a Dutch-Icelandic medical startup that was established to improve medication safety in hospitals and care institutions. MedEye, Mint Solutions’ flagship solution, aims to ensure that patients get the right medication, at the right dose and at the right time. For more information: www.mintsolutions.eu.
About LSP
LSP (Life Sciences Partners) is an independent European investment firm, providing financing for private and public life sciences companies. LSP’s mission is to connect investors to inventors, focusing on unmet medical needs. Since the late 1980s, LSP’s management has invested in about 100 innovative enterprises, many of which have grown to become leaders of the global life sciences industry. With over €1 billion of investment capital raised to date and offices in Amsterdam, Munich and Boston, LSP is one of Europe’s leading life sciences investors. The LSP Health Economics Fund invests in innovative products that can increase the quality of health care, while reducing the cost of care. For more information: www.lspvc.com.
Contact:
Anne Portwich, PhD
Partner LSP
+31 20 6645500